InvestorsHub Logo
Followers 20
Posts 2398
Boards Moderated 0
Alias Born 01/27/2022

Re: golden flyer post# 420375

Tuesday, 01/16/2024 9:58:39 AM

Tuesday, January 16, 2024 9:58:39 AM

Post# of 424149
There's no single drug (including Vascepa) that's going to put cardiologists or pharma companies out of business.

A 25% RRR in CVD events is not going to wipe heart disease off the map like some sort of vaccine.

15M+ people in the U.S. have heart disease. If every single one of them took Vascepa, and you lower that to 12M, there's still plenty of disease to go around.

And since only a teeny fraction of those 15M+ are going to take Vascepa anyway, nobody is worried about Vascepa destroying CV practices.

Besides, people that take Vascepa STILL have heart disease, it's just being treated.

If anything, the industry would have been a lot more worried when statins went generic. Statins have a far greater impact on CVD than Vascepa ever will.

ive made these same comments years ago....anyone else notice that cancer has not been cured? it cant be!!!! hundreds of thousands of jobs would be lost and hundreds of billions of dollars....same thing here to maybe a lesser extent......imagine a hospital losing their pulmonary artery stenting dept revenue, drug companies losing revenue from their best selling drugs,cardiologists closing practices? there has been a driving force behind destroying this company since reduce -it and it is still at full force for reasons listed above

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News